Thromb Haemost 1982; 48(01): 108-111
DOI: 10.1055/s-0038-1657230
International Committee Communications
Schattauer GmbH Stuttgart

Bleeding Time in Rats: A Comparison of Different Experimental Conditions

Elisabetta Dejana
The Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
,
Silvia Villa
The Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
,
Giovanni de Gaetano
The Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 26 April 1982

Accepted 25 May 1982

Publication Date:
13 July 2018 (online)

Summary

The tail bleeding time (BT) in rats definitely varies according to the method applied. Of the various variables that may influence BT, we have evaluated the position (horizontal or vertical) of the tail, the environment (air or saline), the temperature (4°, 23° or 37° C) and the type of anaesthesia. Transection of the tail tip cannot be used to screen drugs active on platelet function since it is sensitive to coagulation defects. Template BT in contrast is not modified by heparin and is sensitive to defects of platelet number and function (“storage pool disease”, dipyridamole-like drugs, exogenous prostacyclin). In contrast the test fails to detect aspirin-induced platelet dysfunction. The evidence reported indicates that thromboxane A2-prostacyclin balance is not a factor regulating BT. Aspirin treatment however may be a precipitating factor when associated with other abnormalities of platelet function.

Template BT is a valid screening test for platelet disorders and for antiplatelet drugs.

 
  • References

  • 1 Stella L, Donati MB, de Gaetano G. Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thromb Res 1975; 7: 709-716
  • 2 De Clerck F, Goossens J, Reneman R. Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats. Thromb Res 1976; 8: 179-193
  • 3 Davis JW, Phillips PE, Ellison JM, Lucas SR. Effect of aspirin on bleeding time and survival of rats after head trauma. J Med (Basel) 1974; 5: 229-233
  • 4 Minsker DH, Kling PJ. Bleeding time in rats is prolonged by aspirin. Thromb Res 1977; 10: 619-622
  • 5 Dejana E, Callioni A, Quintana A, de Gaetano G. Bleeding time in laboratory animals, II. A comparison of different assay conditions in rats. Thromb Res 1979; 15: 191-197
  • 6 Bowie EJW, Owen Jr CA. The bleeding time. Prog Hemostasis Thromb 1974; 2: 249-271
  • 7 Copley AL. Editorial: Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage. Thromb Res 1974; 4: 1-23
  • 8 Bonaccorsi A, Dejana E, Quintana A. Organ blood flow measured with microspheres in the unanesthetized rat: effects of three room temperatures. J. Pharmacol Methods 1978; 1: 321-328
  • 9 Dejana E, Quintana A, Callioni A, de Gaetano G. Bleeding time in laboratory animals. III. Do tail bleeding times in rats only measure a platelet defect? (The aspirin puzzle). Thromb Res 1979; 15: 199-207
  • 10 Villa S, Livio M, de Gaetano G. The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
  • 11 Tschopp TB, Weiss HJ. Decreased ATP, ADP and serotonin in young platelets of fawn-hooded rats with storage pool disease. Thrombos Diathes Haemorrh 1974; 32: 670-677
  • 12 Reyers-Degli InnocentiI, Poggi A, de Gaetano G. Platelet aggregation and haemolysis induced in rats by intravenous infusion of ADP – effect of potentially antithrombotic drugs. Scand J Haematol 1974; 13: 331-337
  • 13 Tomikawa M, Ashida S, Kakihata K, Abiko Y. Anti-thrombotic action of ticlopidine, a new platelet aggregation inhibitor. Thromb Res 1978; 12: 1157-1164
  • 14 Dejana E, Barbieri B, de Gaetano G. “Aspirinated” platelets are hemostatic in thrombocytopenic rats with “nonaspirinated” vessel walls – evidence from an exchange transfusion model. Blood 1980; 56: 959-962
  • 15 Villa S, de Gaetano G. Bleeding time in laboratory animals. IV. Effects of prostacyclin, pyrimido-pyrimidine compounds and aspirin in rats. Thromb Res 1979; 15: 727-732
  • 16 Moncada S, Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1978; 1: 1286-1289
  • 17 Cazenave JP, Kinlough-Rathbone RL, Packham MA, Mustard JF. The effect of acetylsalicylic add and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit. Thromb Res 1978; 13: 971-981
  • 18 Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 1981; 304: 76-79
  • 19 Kaneshiro MM, Mielke Jr CH, Kasper CK, Rapaport SI. Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med 1969; 281: 1039-1042
  • 20 Stuart MJ, Miller ML, Davey FR, Wolk JA. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979; 43: 649-659
  • 21 Dejana E, Barbieri B, Cerletti C, Livio M, de Gaetano G. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats. Br J Haematol 1980; 46: 465-469